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ABSTRACT
Bacterial pneumonia is a common and serious clinical
entity. Alveolar epithelial cells and alveolar macrophages
are the first line of defense in the innate immunity against
bacterial pathogens. Epithelial cells are known to release
chemokines/cytokines that recruit and activate phago-
cytic cells. However, the signals sent from alveolar
macrophages back to the lung epithelial cells remain
largely unexplored. We found that LPS, a well-
recognized stimulator derived from gram-negative (G2)
bacteria, rapidly and robustly induces the secretion of
macrophage-derived extracellular vesicles (EVs). The
main type of EVs found in the early stages after LPS
stimulation are apoptotic bodies (ABs) and not micro-
vesicles (MVs) or exosomes (Exos). Furthermore, LPS
markedly up-regulate the levels of a repertoire of
microRNAs (miRNAs) in the macrophage-derived ABs,
including miR-221 and miR-222. Functionally, the LPS-
induced, macrophage-derived ABs promote the pro-
liferation of malignant and/or normal lung epithelial cells.
We next directly transfected miR-221 and/or miR-222
inhibitors into the LPS-induced ABs. Deletion of miR-221/
222 in ABs significantly reduces the AB-mediated
proliferation of lung epithelial cells. Mechanistically,
AB-shuttling miR-221/222 promote cell growth by mod-
ulating cyclin-dependent kinase inhibitor 1B (CDKN1B)
pathways. Collectively, LPS-induced, macrophage-
derived ABs promote the proliferation of their recipient
epithelial cells, partially via AB-shuttling miRNAs.
J. Leukoc. Biol. 101: 1349–1359; 2017.
Introduction
Pneumonia is a very common pulmonary entity in the United
States [1]. Lung infections caused by G2 bacteria are of
particular concern, given that these organisms are highly
efficient in acquiring antibiotic drug resistance [2]. Therefore,
innate immunity plays a primary and non-negligible role in lung
antimicrobial defenses [3]. The innate immune system includes
but is not limited to alveolar macrophages and the epithelial cells
lining the alveolar surface.
Macrophages, the first arm of defense in the immune system,
play a crucial role in innate immunity and host defenses upon
bacterial infection. Macrophages, once activated (classic, or M1
activation), develop an enhanced capacity to engulf bacteria,
release inflammatory cytokines/chemokines, NO/reactive oxy-
gen species, and present MHC class II antigen [4–6]. A
substantial number of molecules are released from the macro-
phages during their activation. The effect of macrophage-derived
signals on adjacent and distant recipient cells, such as lung
cancer cells or normal lung epithelial cells, is incompletely
understood. Recent evidence suggests that most cells constantly
release EVs, and EVs are believed to augment intercellular
communications upon exposure to noxious stimuli [7]. EV
generation is a dynamic process, and EVs are classified into 3
main groups, namely ABs, MVs, and Exos, per the International
Society for Extracellular Vesicles [8]. In the setting of repetitive
bacterial infections, macrophage-derived ABs may play an
important role in intercellular communication. In this report, we
investigate the effects of macrophage-derived ABs on the
proliferation of lung epithelial cells in the setting of G2 bacterial
infection.
The 3 classes of EVs mainly differ in size and mechanism of
biogenesis. Their contents, size, and membrane composition are
heterogeneous and are largely dictated by the cellular sources
and environmental stimuli [9]. ABs are the largest EVs, with a
diameter in the 1000–5000 nm range, and comparable with
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normal platelets in size [10]. ABs are generated through plasma
membrane blebbing during apoptosis [11]. The content of ABs is
variable and may include mRNAs, long noncoding RNAs, rRNA,
miRNAs, or fragments of these intact RNA molecules [12].
Previous reports have suggested that RNA profiles in the 3 EV
fractions are distinctive [12]. For example, the RNA compo-
nents in MVs and Exos are altered later than those in ABs [12].
The findings of miRNAs in EVs have shed light on novel
mechanisms of tumor growth and metastasis [13]. Whereas
many researchers focus on characterizing the miRNA profiles in
Exos or MVs, surprisingly, recent reports suggest that the copy
numbers of “highly up-regulated” miRNAs found in tumor cells
are, in fact, very low in individual Exos detected in plasma
[14–16]. This observation has raised the question of whether
the exosomal miRNAs can have physiologic or pathologic
effects on their recipient cells. Interestingly, oncogenic DNAs
were initially identified in ABs [17]. However, to date, we have
very limited understanding of the roles of RNA contained in AB
compared with those found in MVs/Exos. Presumably, apo-
ptotic cells, in the process of dying, constantly broadcast the
“danger” and “defense” signals to adjacent and distant cells via
many different molecules, including but not limited to
cytokines, Exos, and MVs, among others.
In this study, we focused on exploring the effects of
macrophage-derived AB and AB-containing miRNAs on the fate
of lung epithelial cells. We adopted the G2 bacterial pneumonia
models and used G2 bacteria-derived LPS to induce
macrophage-derived ABs.
MATERIALS AND METHODS
Chemicals and reagents
miRNA-221 mimics (HMI0398), miRNA-222 mimics (HMI0400), and LPS
from Escherichia coli 026:B6 (L3755) were purchased from Sigma-Aldrich
(St. Louis, MO, USA). miRNA-221 and miRNA-222 inhibitors were purchased
from Integrated DNA Technologies (Coralville, IA, USA). Mouse anti-p27
(sc-1641) and rabbit anti-PCNA (sc-7907) were purchased from Santa Cruz
Biotechnology (Dallas, TX, USA).
Animals
Wild-type C57BL/6 mice (male, 6–8 wk of age) were obtained from Charles
River Laboratories (Wilmington, MA, USA). All of the protocols involving
animals in this study were approved by the Institutional Animal Care and Use
Committee of Boston University. All experimental protocols and methods
were approved by Boston University and were carried out in accordance with
the approved guidelines.
Cell culture and drug treatment
A549, BEAS2B, and RAW 264.7 cells (American Type Culture Collection,
Manassas, VA, USA) were cultured in DMEM medium with 10% FBS. H1299,
MH-S, and THP-1 (American Type Culture Collection) were cultured in
RPMI-1640 medium with 10% FBS. The murine alveolar type I epithelial cell-
like cell line E10 (obtained from the late Dr. Alvin Malkinson, University of
Colorado, Aurora, CO, USA) was cultured in CMRL1066 medium, as
previously described [18]. The differentiation of THP-1 monocytes into
macrophages was induced by 5 ng/ml PMA, according to a previous report
[19]. Cultures were incubated at 37°C in a humidified 5% CO2 incubator
(Thermo Fisher Scientific, Waltham, MA). Cells were grown until they
reached 70–80% confluence, at which time, they were subjected to the
experiment.
LPS was dissolved in PBS, and macrophages were treated with
1 mg/ml, whereas control cells received PBS only as previously
described [20].
Isolation and differentiation of BMDMs
Mouse bone marrow was isolated as previously described [21] and was
cultured with 30% L929 cell conditioned medium in complete DMEM for
7 d before any further experimental procedure. L929 cells were purchased
from American Type Culture Collection.
To prepare L929 cell conditioned medium, L929 cells were cultured in
DMEM media with 10% FBS at 37°C in a 5% CO2 incubator. Cell culture
media were collected and filtered using 0.22 mm filters.
Categorization of the EVs
Three types of EVs were prepared by using sequential centrifugation
protocols described previously with a minor modification [12, 20, 22].
Cultured cells were incubated with culture medium containing EV-
depleted FBS for designated time points. Conditioned medium was
collected and centrifuged at 300 g for 10 min to remove floating cells.
The supernatant was further centrifuged at 2000 g for 20 min to pellet
ABs. To isolate MVs, the AB-depleted supernatant was passed through a
0.8 mm pore filter, followed by centrifugation at 16,000 g for 40 min.
Finally, the resulting supernatant was passed through a 0.2 mm pore filter
and ultracentrifuged at 100,000 g for 1 h to pellet Exos. Each type of
vesicle was washed further with cold PBS, then resuspended with PBS,
and stored at 280°C. Protein concentration was measured with a
Bradford assay.
Uptake of macrophage-derived ABs
ABs from macrophages were stained with Annexin V-FITC (BioVision,
Milpitas, CA, USA), with a ratio of 1:200 for 30 min, and incubated with
recipient cells for 10 min. The recipient cells were then visualized with PKH26
Red Fluorescent Cell Linker Kit (Sigma-Aldrich). Images were obtained with
3400 fluorescent microscopy (Axioskop 40; Zeiss, Thornwood, NY, USA).
DLS analysis
The size of EVs was analyzed using the DLS instrument 90Plus. Nanoparticle Size
Analyzer (Brookhaven Instruments, Holtsville, NY, USA). For calculating the
absolute EV number, a standard calibration curve (particle number vs. count
rate) was generated using DLS (R2 = 0.9978). Count rate of each EV sample was
measured by DLS, followed by calculation of the absolute vesicle number.
Immunofluorescence
Immunofluorescence was performed as previously described [23–26].
Images were captured using a fluorescence microscope (Eclipse TS100;
Nikon Instruments, Melville, NY, USA) at 320 magnification and
analyzed using ImageJ software (National Institutes of Health, Bethesda,
MD, USA).
RNA preparation, RT, and real-time qPCR
SYBR Green-based real-time qPCR technique was performed for detection of
miRNAs, as previously described [23–26]. Total RNAs were purified from
isolated ABs using the miRNeasy Mini Kit (Qiagen, Germantown, MD, USA).
Purified RNA amount was measured by NanoDrop Lite Spectrophotometer
(Thermo Fisher Scientific). Reverse Transcription Kit (Thermo Fisher
Scientific) was used to generate single-stranded cDNA from an equal amount
of purified RNAs.
CCK-8 assay
The CCK-8 detection kit (Sigma-Aldrich) was used to measure cell viability,
according to the manufacturer’s instructions. The viable cells were counted by
absorbance measurements with a monochromator microplate reader at a
wavelength of 450 nm.
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miRNA transfection into ABs
Isolated ABs were incubated with Exo-Fect reagent (System Biosciences, Palo Alto,
CA, USA) and miRNA mimics or inhibitor (10 pM) at 37°C for 10 min and placed
on ice for 30 min, followed by 3 times washing with PBS using 2000 g force
centrifugation. The transfected ABs were then used directly for further experiments.
Western blot analysis
Western blotting analysis was performed as described previously [23–26].
Harvested cells, ABs, MVs, and Exos were lysed with radioimmunoprecipita-
tion assay buffer containing 1% Triton X-100, protease inhibitor, and
phosphatase inhibitor.
Figure 1. Characterization of the EVs generated from macrophages. (A–C) Three types of EVs were isolated from MH-S alveolar macrophage cells,
including ABs, MVs, and Exos. (D–F) Three types of EVs were isolated from THP-1 cells, including ABs, MVs, and Exos. Cells were stimulated with
LPS (1 mg/ml) for 0, 1, 6, 12, and 24 h, followed by the isolation of EVs. (A and D) The amount of EV generations after a time course of LPS.
(B and E) The percentages of each type of EVs, with or without LPS stimulation, presented in pie graphs. (C and F) The sizes of the isolated EVs
measured using DLS. (G–J) ABs were isolated from BMDM and RAW 264.7 after stimulated with LPS (1 mg/ml) for 0, 1, 6, 12, and 24 h. (G and H)
The amount of AB generations after a time course of LPS. (I and J) The sizes of the isolated ABs measured using DLS. (K) Western blot (WB) data
for characterization of THP-1 macrophage-derived ABs. Data represent means 6 SD of 3 independent experiments with identical results. Flot-1,
Flotillin 1; TSG101, tumor susceptibility gene 101.
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Statistics
All data were presented as means 6 SD. Comparisons between 2 groups were
performed using a 2-tailed unpaired Student’s t test. Multiple groups were
compared using a one-way ANOVA with Tukey method. P , 0.05 was
considered statistically significant.
RESULTS
LPS stimulated the generations of
macrophage-derived ABs
LPS are derived from the outer membrane of G2 bacteria and
can trigger strong immune responses in the host. In the setting of
G2 bacterial pneumonia, alveolar macrophages are the first
responders to infection [27]. We initially evaluated the genera-
tion of alveolar macrophage-derived EVs in response to LPS. As
shown in Fig. 1A, LPS induced a rapid and robust release of ABs
from MH-S cells, a cell line of murine alveolar macrophages.
Surprisingly, only minimal up-regulation of MVs or Exos was
found. Percentages of each category of EVs in the absence or
presence of 1 h treatment of LPS were illustrated using pie
graphs (Fig. 1B). Next, we confirmed our findings using human
macrophages, THP-1. Although slightly different compared with
MH-S cells, the immediate up-regulation of ABs is again observed
in these cells (Fig. 1D and E). Furthermore, similar results were
also observed in BMDMs and RAW 264.7 macrophages (Fig. 1G
and H). To confirm that the up-regulated EVs fall into the
category of ABs, we evaluated the sizes of the EVs obtained from
MH-S, THP-1, BMDMs, and RAW 264.7 cells using DLS. Shown in
Fig. 1C, F, I, and J, we confirmed that the dramatically up-
regulated EVs fell into the category of ABs. To characterize further
the macrophage-derived ABs, we performed a Western blot
analysis, according to a previous paper [28]. As shown in Fig. 1K,
Western blot analysis showed that ABs contained ample amounts of
histone H3 and lack the MV/Exo maker, CD9. These data can
prove that these large particles represent AB-like particles [28].
Macrophage-derived ABs induced proliferation of the
recipient epithelial cells
Next, we determined the effects of macrophage-derived ABs on
the recipient epithelial cells. In Fig. 2A, we treated the A549
alveolar epithelial cells with LPS-induced ABs. These ABs were
labeled with Annexin V-FITC. Only after 10 min, uptake of
THP-1-derived ABs by A549 cells was observed (Fig. 2A). Next, we
treated the A549 cells with macrophage-derived ABs in a time-
dependent manner. Surprisingly, we found that ABs induced
A549 proliferation (Fig. 2B). To confirm this observation, we
treated H1299 cells (lung epithelial cell line; Fig. 2C) and normal
lung epithelial Beas2B cells (Fig. 2D) with the macrophage-
derived ABs. Similar results were found in both H1299 and
Beas2B. Furthermore, we were also able to confirm this
Figure 2. The effects of LPS-induced, macrophage-derived ABs on cell survival and proliferation in lung malignant or normal epithelial cells. (A)
Colocalization of the THP-1 macrophage-derived ABs and A549 cells. ABs were labeled with Annexin V-FITC, and the A549 cells membranes were
marked with PKH26 Red. ABs (50 mg/2 ml per well) were added into the cell culture of A549 cells; after 10 min, cells were washed with PBS twice.
Cells were then examined using the confocal microscopy. (B–E) ABs were isolated from the macrophages after LPS (1 mg/ml) stimulation for 0, 6,
and 12 h. The recipient cells were treated with the macrophage (Mf)-derived ABs (50 mg/2 ml per well). The effects of macrophage-derived ABs
on the proliferation of recipient cells were measured using CCK-8 assay. The values of OD (450 nm) represent cell viability. The data represent
means 6 SD of 3 independent experiments. (F and G) Cyclin D3 levels were analyzed using real-time PCR. (F) Human lung epithelial Beas2B cells.
(G) Mouse alveolar epithelial type I cells (E10). (H) Cyclin D3 levels were analyzed using Western blot analysis in Beas2B cells.
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observation in normal murine alveolar epithelial cells (E10) after
being exposed to MH-S-derived ABs (Fig. 2E and Supplemental
Fig. 1). Moreover, we confirmed that the cyclin D3 levels in the
epithelial cells were altered after exposure to macrophage-
derived ABs (Fig. 2F–H) using real-time PCR and Western blot
analysis. Additionally, we analyzed the cell death of epithelial
cells after exposure to macrophage-derived ABs. Consistently, we
found no significant cell death or apoptosis in the recipient cells
after the treatment of ABs (Supplemental Fig. 3).
miR-221/222 up-regulated in macrophage-derived ABs
To determine the underlying mechanisms by which AB induces cell
proliferation, we investigated the effects of LPS on the modification
of AB components. We found that LPS induced miR-221 and -222
up-regulation in MH-S-derived ABs (Fig. 3A and B). To confirm
that this observation is unique to miR-221 or -222, we tested several
other miRNAs. For instance, LPS failed to induce a significant
change in AB enwrapped miR-16, as shown in Fig. 3C. With the use
of THP-1 human macrophages, we confirmed the above observa-
tion in MH-S murine macrophages as well (Fig. 3D–F).
Macrophage-derived ABs induced proliferation of the
recipient epithelial cells via miR-221/222
To test whether macrophage-derived ABs induced cell pro-
liferation via the up-regulated miR-221/222 in ABs, we first
manipulated the level of miR-221/222 in macrophage-derived
ABs by introducing miR-221 and/or miR-222 mimics or
inhibitors. As shown in Fig. 4A, miR-221 or miR-222 mimics
enhanced cell proliferation. Additionally, miR-221 and miR-222
mimics exhibited a synergistic effect (Fig. 4A). This result was
confirmed using 2 separate methods: WST-8 [29] (Fig. 4A) and
PCNA [30] (Fig. 4B). On the other hand, miR-221 or miR-222
inhibitors robustly suppressed AB-induced cell proliferation. miR-
221 and miR-222 inhibitors were also seen to exert a synergistic
effect consistently (Fig. 4C). This result was again confirmed using
2 separate methods: WST-8 (Fig. 4C) and PCNA (Fig. 4D).
miR-221/222 overexpression promotes cell growth via
suppressing CDKN1B in normal lung epithelial cells
The effect of miR-221/222 has been studied in the A549 nonsmall
cell lung cancer cell line [31]. We exposed normal murine alveolar
epithelial cells (E10) with miR-221 or miR-222 mimics. Over-
expression of miR-221/222 promoted E10 cell proliferation, as
detected using PCNA methods (Fig. 5A and B). Interestingly, we
observed a marked knockdown of CDKN1B (p27Kip1) in murine
alveolar epithelial cells after introducing miR-221 or miR-222
mimics (Fig. 5C and D). The inhibition by miR-221/222 is unique
to CDKN1B, given that opposite effects were found in CDKN1A
and CDKN1C (Fig. 5E and F). Similar results were confirmed in
human lung epithelial cells (Fig. 5G–I).
Figure 3. LPS induce miR-221/222 expression in macrophage-derived ABs. RNA was isolated from the macrophage-derived ABs after LPS
stimulation for 0, 1, 6, 12, and 24 h and quantified using the real-time qPCR. miRNA expression levels were shown in bar graphs. (A–C) miR-221,
miR-222, and miR-16 expressions in MH-S-derived ABs. (D–F) miR-221, miR-222, and miR-16 expressions in THP-1-derived ABs. All of the data
represent means 6 sd of 3 independent experiments. ***P , 0.001. mmu, Mus musculus ; hsa, Homo sapiens.
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Macrophage-derived ABs suppress CDKN1B expression
via miR-221/222
Next, we determined the effects of macrophage-derived ABs on
the expression of miR-221/222. We treated human lung cancer
A549 cells with LPS-induced ABs. LPS-induced ABs suppressed
the expression of CDKN1B. This effect was observed in the ABs
induced as early as 6 h after exposure of LPS (Fig. 6A and
Supplemental Fig. S2). On the other hand, ABs failed to exert
significant effects on the expression of CDKN1A, whereas an
up-regulation, but not suppression, was observed in the
expression of CDKN1C (Fig. 6B and C). Similar results were
also found using normal lung epithelial cells (Fig. 6D–F). We
introduced the miR-221/222 mimics or inhibitors into LPS-
induced, macrophage-derived ABs, and the A549 cells were
treated with these manipulated ABs. Addition of miR-221 or
miR-222 mimics synergistically exaggerated the AB-mediated
suppression of CDKN1B in A549 cells (Fig. 6G). Consistently,
the miR-221 inhibitor or miR-222 inhibitor reversed the effects
of ABs on CDKN1B in A549 cells. Moreover, miR-221 and -222
and ABs exerted a synergistic effect on CDKN1B in A549 cells
(Fig. 6H).
Macrophage-derived ABs induce the cyclin D3 and
Cdk4 expression via the miR-221/222
Given that CDKN1B prevents the activation of cyclin D-CDK4
complexes and subsequently controls the cell-cycle progres-
sion at G1, it is often considered a tumor suppressor [32–34].
We treated the A549 cells with macrophage-derived ABs, miR-
221 mimic-enhanced ABs and miR-222 mimic-enhanced ABs.
Up-regulation of cyclin D3 was found in all of the above-
treated cells (Fig. 7A). More importantly, a significant
synergistic effect was found in the cells treated with miRNA
mimic-enhanced ABs (Fig. 7C). Consistently, miRNA
inhibitor-enhanced ABs markedly reversed the effects of ABs
on cyclin D3 expression (Fig. 7D). Likewise, miRNA mimic-
enhanced ABs up-regulated the Cdk4 level, whereas miRNA
inhibitor-enhanced ABs suppressed the Cdk4 level in A549
cells (Fig. 7B, E, and F).
DISCUSSION
EVs have been considered as novel targets for the development
of diagnostic, prognostic, and therapeutic agents [35]. EVs
potentially act as a carrier to transport and exchange molecular
information among different types of cells, tissues, and organs
[35, 36]. Whereas intensive studies have focused on the role of
EVs originated from cancer cells, the generation and function of
EVs from immunomodulatory cells remain largely unexplored.
Furthermore, it is also unclear whether these EVs mediate the
cross-talk between the immunomodulatory cells and benign or
malignant epithelial cells. Our studies show that after LPS
stimulation, the macrophage-derived EVs, particularly the ABs,
regulate lung epithelial cell growth. To our best knowledge, this
is the first study exploring the intercellular communications via
EVs between the activated macrophages and lung epithelial cells.
Our study potentially provides novel insights into lung epithelial
cell propagation and tumorigenesis (Fig. 8).
Previously, most EV research focused on the roles of MVs or
Exos. Our studies demonstrate that after LPS stimulation, ABs,
rather than MVs or Exos, are the main type of EVs generated by
stimulated macrophages. Therefore, our studies have focused on
the role of ABs in the survival and death of epithelial cells. As
previously mentioned, ABs fall into the 1000–5000 nm range in
diameter and are comparable with the size of platelets. As the
largest one among all 3 types of EVs, ABs are much more diverse
in their morphology, composition, function, and biogenesis, as
compared with MVs and Exos [8]. Despite the fact that
classifications of EVs are primarily made on their sizes,
Figure 4. Synergistic effects of AB-containing
miR-222 and miR-222 on the cell proliferation.
(A and B) Transfection with miR-221 and/or
miR-222 mimics induces the proliferative effect of
macrophage-derived ABs. (C and D) Transfection
with miR-221 and/or miR-222 inhibitors sup-
presses the proliferative effect of macrophage-
derived ABs. ABs were isolated from the THP-1
cells and directly transfected with miR-221 and/
or miR-222 mimics or inhibitor, as described in
Materials and Methods. The recipient A549 cells
were treated with the LPS-induced ABs, ABs with
control RNAs, or ABs with miRNA mimics or
inhibitor (50 mg/2 ml per well). Cell viability was
determined using the CCK-8 assays. (B and D)
Relative mRNA level of PCNA was detected in
A549 cells treated with ABs transfected with miR-
221 and/or miR-222 mimics (B) or inhibitor (D).
Data represent means 6 SD of 3 independent
experiments. **P , 0.01; ***P , 0.001.
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differential compositions do exist within the various types of EVs.
For example, recent reports suggest that RNA profiles in the 3
types of EVs are different [12]. Particularly, ABs and not MVs
and/or Exos are believed to contribute the majority of RNA
compositions analyzed in the EVs [12]. Moreover, as a result of
the significantly larger size of ABs, more diverse contents are
found in the ABs, including but not limited to proteins, lipids,
RNA, and DNA molecules [12]. Presumably, ABs would confer
more robust effects on their downstream cells or recipient cells,
given their larger pool of encapsulated molecules. That said,
major advances on EVs and cancer biology were achieved by
targeting Exos and/or MVs. Malignant cells are shown to
“engulf” the nano-sized Exos in a variety of reports [37].
Caveolae-dependent or -independent endocytosis are thought to
play essential roles in this process [38]. These findings provide
crucial bases for the development of novel drug delivery systems
using Exo-shuttling methods, which potentially can be cancer
cell specific. On the other hand, ABs, as a result of their larger
size, are presumably difficult to be taken up by the recipient
cells via endocytosis. Initially, we assumed that ABs would exert
effects via contact with surface proteins on the recipient cells. As
shown in Fig. 2A, we found that Annexin V-FITC-labeled ABs
Figure 5. miR-221 and miR-222 overexpression promotes cell growth through CDKN1B inhibition in lung epithelial cells. (A–F) Murine alveolar
epithelial E10 cells were transfected with control or miR-221/222 mimics for 48 h. (A) The relative PCNA mRNA level was detected by qPCR. (B)
PCNA immunofluorescence was used to detect proliferation in E10 cells transfected with control or miR-221/222 mimics. Representative images
were captured using a fluorescent microscope at 3100 magnification. (C) CDKN1B immunofluorescence was used to confirm the CDKN1B mRNA
change in E10 cells transfected with control or miR-221/222 mimics. Representative images were captured using a fluorescent microscope at 3200
magnification. (D–F) The relative CDKN1B, CDKN1A, and CDKN1C mRNA levels were detected using qPCR after transfection. (G–J) The relative
CDKN1B, CDKN1A, and CDKN1C mRNA levels were detected in human lung epithelial BEAS-2B cells using qPCR after transfection. Data represent
means 6 SD of 3 independent experiments. ***P , 0.001.
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(green) colocalized with the PKH26 Red-labeled A549 cell
membranes. However, given that confocal microscopy cannot be
used to examine 3-dimensional subjects, it is unclear whether the
ABs were engulfed partially or entirely into the epithelial cells or
if they were mainly interacting with the cell-surface molecules.
That said, this contact probably does cause structural changes to
the lipid bilayer cell membrane via either a caveolae-dependent
or -independent mechanism. The alteration of the cell-surface
membrane, in fact, has been widely observed and reported in EV
research, including the modification of cell-surface molecules
through glycosylation and palmitoylation [39].
We discovered that miR-221 and miR-222, 2 known miRNAs
involved in cancer cell growth [40], were up-regulated in the
macrophage-derived ABs after LPS (Fig. 3). More interestingly,
these 2 AB-shuttling miRNAs were highly functional in the
process of promoting epithelial cell proliferation (Fig. 4). Both
miR-221 and -222 have been predicted to target the CDKN1B
(p27Kip1) gene, and our studies confirm this result (Fig. 5).
Therefore, we believe that ABs or AB-shuttling compositions,
such as miRNAs, are at least partially engulfed by the recipient
epithelial cells. This probably occurs via recipient cell-surface
modification triggered by AB/recipient cell contact.
Among all the AB-encapsulated compositions, compared with
the larger and more complex proteins—RNA and DNA
molecules—miRNAs are potentially the most powerful ones to
result in significant effects on the recipient cells. They are;20 nt
noncoding, small RNAs and directly target the designated genes
in the nucleus [41], which in our study, was the CDKN1B
(p27Kip1) gene. miRNAs are small and relatively more stable, as
compared with the larger RNA or DNA molecules. They probably
interact with certain permeable peptides and/or “flip-flop”
proteins on the cell surface and subsequently, get transported
intracellularly to the recipient cells. The detailed mechanism
behind this process, however, remains to be explored.
Despite previous reports of only endogenous miR-221/222-
mediated cell proliferations in A549 cells [40], our studies were
Figure 6. Macrophage-derived ABs suppress the
CDKN1B expression through the miR-221/222.
(A–C) A549 cells were treated with macrophage-
derived ABs, as described in Materials and
Methods. The relative CDKN1B, CDKN1A, and
CDKN1C mRNA levels were detected using
qPCR. (D–F) Human BEAS-2B lung epithelial
cells were treated with macrophage-derived ABs.
The relative CDKN1B, CDKN1A, and CDKN1C
mRNA levels were detected using qPCR. (G)
Macrophage-derived ABs transfected with miR-
221 and/or miR-222 mimics induced the down-
regulation of CDKN1B(p27Kip1) in A549 cells.
(H) Macrophage-derived ABs transfected with
miR-221 and/or miR-222 inhibitor reduced the
down-regulation of CDKN1B(p27Kip1) in A549
cells. ABs were isolated from the THP-1 cells and
directly transfected with miR-221 and/or miR-222
mimics or inhibitor, as described in Materials and
Methods. The recipient A549 cells were treated
with the LPS-induced ABs, ABs with control
RNAs, or ABs with miRNA mimics or inhibitor
(50 mg/2 ml per well). Data represent means 6 SD
of 3 independent experiments. *P , 0.05; **P ,
0.01; ***P , 0.001.
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able to extrapolate this observation to an exogenous source of
miR-221/222, i.e., the LPS-induced, macrophage-derived, AB-
containing miR-221/222. This observation demonstrates for the
first time that a cross-talk exists between the infection-activated
macrophages and lung epithelial cells in the setting of G2
bacterial infections. Additionally, we report that the AB-
shuttling miR-221/222 induces cell proliferation in primary
lung epithelial cells too. However, it is premature to conclude
that repeated bacterial infections may contribute to lung
epithelial cell tumorigenesis. Many questions remain to be
answered through further studies . These questions include but
are not limited to the concentration and amount of specific
miRNAs in each ABs induced by LPS or G2 bacterial infection;
the effective “dose” or “amount” of ABs/AB-shuttling miRNAs
to trigger cell growth; and the efficacy of AB-shuttling miRNAs
to enter the recipient cells. There is yet to be a study comparing
the half-lives between exogenous, AB-delivering miRNAs and
the endogenous miRNAs; looking at the underlying mecha-
nisms by which AB-shuttling miRNAs enter the recipient cells;
or comparing the generation of macrophage-derived ABs in G+
bacterial infection versus G2 bacterial infection. Currently, our
studies adopted the miRNA mimics and/or inhibitors to
manipulate directly the amount of miR-221/222 in the ABs.
This approach certainly carries a disadvantage, which is that it is less
likely to reflect the precise and pathophysiological level of miRNAs
in the ABs and/or recipient cells. However, on the other hand, it
suggests that manipulation of AB-containing miRNAs can poten-
tially be applied as a novel therapeutic target.
Our studies also illustrate the complexity of developing
therapeutic targets using EV or EV compositions. The differential
type of EVs involved in the pathogenesis requires a detailed
characterization that is probably stimulation dependent and cell-
type dependent. Multiple compositions in each type of EVs
probably collectively participate in a disease process and so do
the synergistic effects of different EV compositions. The other
significance of our studies includes the following: LPS-induced,
macrophage-derived ABs functioned as a messenger to lung
epithelium and helped to maintain its integrity via promotion of
epithelial cell proliferation. This may contribute a novel
concept in lung epithelial cell turnover in the presence of
infectious insults. Conventionally, type II epithelial cells are
believed to be responsible for replacing/repairing damaged
Figure 7. Macrophage-derived ABs induce the cyclin D3 and Cdk4 expression through the miR-221/222. (A and B) A549 cells were treated with
macrophage-derived ABs. The relative cyclin D3 and Cdk4 mRNA levels were detected using qPCR. (C and D) Macrophage-derived ABs transfected
with miR-221 and/or miR-222 mimics induced the up-regulation of cyclin D3 and Cdk4 in A549 cells. (E and F) Macrophage-derived ABs
transfected with miR-221 and/or miR-222 inhibitor reduced the up-regulation of cyclin D3 and Cdk4 in A549 cells. ABs were isolated from the
THP-1 cells and directly transfected with miR-221 and/or miR-222 mimics or inhibitor, as described in Materials and Methods. The recipient A549
cells were treated with the LPS-induced ABs, ABs with control RNAs, or ABs with miRNA mimics or inhibitor (50 mg/2 ml per well). Data represent
means 6 SD of 3 independent experiments. *P , 0.05; **P , 0.01; ***P , 0.001.
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type I cells. Our study suggests that AB-stimulated type I
epithelial cell proliferation may also contribute to the integrity
of epithelium in the presence of infectious insults. However,
whether repetitive exposure to the proproliferative ABs triggers
unregulated tumor-like proliferation of epithelial cells requires
further investigation.
In summary, our report finds that macrophages release a
significant amount of ABs after LPS, rather than MVs and Exos.
The LPS-induced, macrophage-derived ABs promote the pro-
liferation of recipient epithelial cells via AB-shuttling miR-221/
222 and miR-221/222-targeted CDKN1B pathways.
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